These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37878255)

  • 21. Prenatal exposure to poly-/per-fluoroalkyl substances is associated with alteration of lipid profiles in cord-blood.
    Sinisalu L; Yeung LWY; Wang J; Pan Y; Dai J; Hyötyläinen T
    Metabolomics; 2021 Nov; 17(12):103. PubMed ID: 34816353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can profiles of poly- and Perfluoroalkyl substances (PFASs) in human serum provide information on major exposure sources?
    Hu XC; Dassuncao C; Zhang X; Grandjean P; Weihe P; Webster GM; Nielsen F; Sunderland EM
    Environ Health; 2018 Feb; 17(1):11. PubMed ID: 29391068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
    Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
    Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water.
    Li Y; Barregard L; Xu Y; Scott K; Pineda D; Lindh CH; Jakobsson K; Fletcher T
    Environ Health; 2020 Mar; 19(1):33. PubMed ID: 32169067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To which extent are per-and poly-fluorinated substances associated to metabolic syndrome?
    Zare Jeddi M; Soltanmohammadi R; Barbieri G; Fabricio ASC; Pitter G; Dalla Zuanna T; Canova C
    Rev Environ Health; 2022 Jun; 37(2):211-228. PubMed ID: 34036763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
    Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
    Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Per and poly-fluoroalkyl substances (PFAS) as a contaminant of emerging concern in surface water: A transboundary review of their occurrences and toxicity effects.
    Podder A; Sadmani AHMA; Reinhart D; Chang NB; Goel R
    J Hazard Mater; 2021 Oct; 419():126361. PubMed ID: 34157464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study.
    Tanner EM; Bloom MS; Wu Q; Kannan K; Yucel RM; Shrestha S; Fitzgerald EF
    Int Arch Occup Environ Health; 2018 Feb; 91(2):145-154. PubMed ID: 29027000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid.
    Girardi P; Merler E
    Environ Res; 2019 Dec; 179(Pt A):108743. PubMed ID: 31542491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between prenatal or early postnatal exposure to perfluoroalkyl substances and language development in 18 to 36-month-old children from the Odense Child Cohort.
    Beck IH; Bilenberg N; Andersen HR; Trecca F; Bleses D; Jensen TK
    Environ Health; 2023 May; 22(1):46. PubMed ID: 37254153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort.
    Birukov A; Andersen LB; Andersen MS; Nielsen JH; Nielsen F; Kyhl HB; Jørgensen JS; Grandjean P; Dechend R; Jensen TK
    Environ Int; 2021 Jun; 151():106442. PubMed ID: 33610053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
    Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
    Environ Int; 2022 Nov; 169():107537. PubMed ID: 36183490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.
    Worley RR; Moore SM; Tierney BC; Ye X; Calafat AM; Campbell S; Woudneh MB; Fisher J
    Environ Int; 2017 Sep; 106():135-143. PubMed ID: 28645013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies.
    Forns J; Verner MA; Iszatt N; Nowack N; Bach CC; Vrijheid M; Costa O; Andiarena A; Sovcikova E; Høyer BB; Wittsiepe J; Lopez-Espinosa MJ; Ibarluzea J; Hertz-Picciotto I; Toft G; Stigum H; Guxens M; Liew Z; Eggesbø M
    Environ Health Perspect; 2020 May; 128(5):57002. PubMed ID: 32378965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PFAS and cancer, a scoping review of the epidemiologic evidence.
    Steenland K; Winquist A
    Environ Res; 2021 Mar; 194():110690. PubMed ID: 33385391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense Child Cohort.
    Beck IH; Timmermann CAG; Nielsen F; Schoeters G; Jøhnk C; Kyhl HB; Høst A; Jensen TK
    Environ Health; 2019 Nov; 18(1):97. PubMed ID: 31730470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.